ClinicalTrials.gg
CompletedNCT02759484MATCH2Updated Aug 18, 2022

Multi-clinic Action Trial to Control Hyperglycemia and Hypertension

An interventional study of Home Based Enhanced Education and Clinic Based Enhanced Education in Diabetes Mellitus, Type 2, sponsored by Rush University Medical Center. Completed at 3 sites in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2022-08-18.

Sponsored by Rush University Medical Center · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
244
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The MATCH2 Study (The Multi-clinic Action Trial to Control Hyperglycemia and Hypertension) is a randomized controlled trial comparing two educational approaches to improve glucose and blood pressure control in African American and Latino adults with type 2 diabetes. The study is being designed and implemented using a Community Based Participatory Research approach to optimize the two educational approaches. One approach, Enhanced Home Based Education, adapts a Community Health Worker (CHW) intervention from the protocol of the prior Mexican-American Trial of Community Health workers (MATCH). The other approach, Enhanced Clinic Based Education, uses a Certified Diabetes Educator (CDE) to deliver dietary and general self-management education. The study seeks to determine if Community Health Workers working as part of the primary care clinical team can reduce health disparities and improve outcomes among patients with type 2 diabetes.

Read the detailed description

MATCH2, a randomized controlled trial, will test if the optimized CHW-delivered intervention can reduce both Hemoglobin A1c levels and blood pressure at eighteen months in persons with uncontrolled diabetes, as compared to a CDE-delivered group educational program. Follow-up six months after the completion of the intervention will evaluate the sustainability of any gains. MATCH2 will use precise measures of diet (food frequency questionnaires) and physical activity (accelerometry) to identify intermediate behaviors and processes that mediate significant improvements in glycemic and blood pressure control.

Patients/participants will be recruited from three participating urban primary care safety net clinics to join MATCH2 if patients meet the inclusion and exclusion conditions (see criteria section below). Eligible patients interested in participation will have a baseline visit scheduled. Baseline assessments may be conducted either at the clinic, the participant's home, or the Rush Prevention Center, at the patient's preference. At the baseline visit, the research assistant will obtain informed consent for the study as approved by the Institutional Review Boards (IRB) of participating institutions. The baseline assessment will include the following measures: demographics, clinical data, glycemic control, blood pressure, total caloric and sodium intake, physical activity, medication adherence, clinic attendance, quality of life, patient activation, depression and social support.

A randomization scheme based on permuted randomized blocks of size 4 and 6 will be used, stratified by clinic. Randomization schedules will be developed by the study Biostatistician and the Data Management Team will assign participants to treatment or control groups accordingly.Of the investigative team, the Principal Investigator, identified Key Co-Investigators and all research assistants will be blinded to the patient's group assignment while remaining research team: the Community Health Workers (blinded to study hypothesis), selected Key Co-Investigators, Site Principal Investigators, and Data Management Team will be unblinded.

Participants will know the study condition to which participants have been assigned. As with the CHW interventionists, participants will be blinded to the study hypothesis. Consent and recruitment forms will all state that "The MATCH2 trial is comparing two clinic-based approaches to improve control of high blood sugar and high blood pressure in people with type 2 diabetes. Some evidence suggests that approaches such as health classes led by a diabetes educator, coaching by Community Health Workers, and printed diabetes education materials may help improve outcomes for people with uncontrolled diabetes.

ENHANCED HOME-BASED EDUCATION CONDITION: CHW Interventionists deliver diabetes self-management curriculum in the participant's home or other preferred setting.

MATCH2 Trained CHW Interventionists will work closely with patients to deliver a participant-centered intervention derived from two pragmatic evidence-based frameworks for behavioral change [Motivational Interviewing (MI) and Kate Lorig's Chronic Disease Self-Management approach]. 24 total in-person visits will be conducted; six primary topics will be covered multiple times over an 18-month period. No more than two topics will be addressed at any visit. The sequence in which topics are delivered is determined by participant need, preference, and interest. The six primary topics are:

  1. Check glucose daily and know the goal.
  2. Check blood pressure daily and know the goal.
  3. Understand medications and take medications as prescribed.
  4. Engage in 30 minutes of physical activity every day.
  5. Enjoy a healthy natural diet with vegetables, fruit, and fiber.
  6. Communicate any concerns to the health care team.

At each visit, CHWs will help participants develop a self-management Action Plan around one of the six topics, and support problem solving behaviors to address barriers to completing the Action Plan. Behavioral self-management skills will be taught by the CHW and practiced with the participant at each visit. CHWs will monitor the clinic attendance of participants and will advise and assist participants with making appointments with their primary care providers at least once every 4 months. CHWs will also play an active role in communicating the progress of their participants to the primary care providers using the clinic Electronic Medical Record.

ENHANCED CLINIC-BASED EDUCATION CONDITION: Participants will receive group diabetes self-management education, consistent with current Medicare guidelines for diabetes education. A Certified Diabetes Educator will deliver the two class sessions (each two hours) covering basic topics: diabetes (including self-management) and nutrition. Participants will also receive 24 bilingual educational newsletters: twelve during the first six months and then once a month between 6 and 18 months. The newsletters, called "Diabetes Action", cover the same six self-management topics listed previously.

02

Conditions studied

  • Diabetes Mellitus, Type 2

Keywords

  • CHWs
  • Health Education
  • Disease Self Management
03

In context

Diabetes Mellitus, Type 2

9,590 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,332 are open to participants now.

This study's enrollment of 244 is above the median of 81 across 7,713 interventional studies indexed under Diabetes Mellitus, Type 2.

Browse Diabetes Mellitus, Type 2 studies →

Lead sponsor

Rush University Medical Center is the lead sponsor of 397 studies on the registry; 61 are open to participants now.

Of its 31 completed or terminated interventional studies of FDA-regulated products, 26 (84%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of type 2 diabetes mellitus with A1c greater than or equal to 7.0
  • At least 18 years of age and capable of giving informed consent in either English or Spanish
  • Primary care received through a participating clinic
  • Participants must identify themselves as either Black / African American race or Hispanic / Latino ethnicity

Exclusion criteria

Exclusion Criteria:

  • Have end-stage renal disease, stroke, or other major end-organ complication of diabetes
  • Require chronic prednisone or other systemic corticosteroid use
  • Are receiving treatment for a major psychiatric disorder (i.e. schizophrenia)
  • Live in a household with someone who is already a randomized study participant
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
244 participants (actual)

Study arms

  • Experimental
    Home Based Enhanced Education

    The Home Based Enhanced Education arm consists of a diabetes self-management curriculum delivered by Community Health Workers in the participant's home.

    Behavioral: Home Based Enhanced Education

  • Active comparator
    Clinic Based Enhanced Education

    The Clinic Based Enhanced Education arm consists of group diabetes self-management education, delivered by a Certified Diabetes Educator, plus mailed diabetes self-management education.

    Behavioral: Clinic Based Enhanced Education

Interventions

  • BehavioralHome Based Enhanced Education

    The Home Based Enhanced Education arm consists of a diabetes self-management curriculum delivered by Community Health Workers in the participant's home. Participants receive 24 visits: 12 biweekly visits in the first 6 months, followed by 12 monthly visits in months 6 through 18 of the study. The self-management program is derived from two pragmatic evidence-based frameworks for behavioral change.

    Also known as: Community Health Worker intervention (CHW)

  • BehavioralClinic Based Enhanced Education

    The Clinic Based Enhanced Education arm consists of two two-hour-long sessions of group diabetes self-management education, delivered by a Certified Diabetes Educator. Participants in this arm will also receive 24 newsletters with diabetes self-management education.

    Also known as: Diabetes Educator intervention

06

What researchers measure

Primary outcomes

  1. Glycemic Control

    Glycemic control will be determined by Hemoglobin A1c, measured on a fingerstick collected Dried Blood Spot test, and analyzed by an independent reference lab.

    Time frame: Up to 18 months post randomization

  2. Blood Pressure Control

    Blood Pressure (BP) will be measured three times using an automated blood pressure cuff with the participant in a seated position. Mean Arterial Pressure will be calculated by the standard formula: Diastolic BP + 1/3 (Systolic BP - Diastolic BP)\] .

    Time frame: Up to 18 months post randomization

Secondary outcomes

  1. Maintenance of Glycemic Control

    Glycemic control will be determined by Hemoglobin A1c, measured on a fingerstick collected Dried Blood Spot test, and analyzed by an independent reference lab.

    Time frame: Up to 24 months post randomization

  2. Maintenance of Blood Pressure Control

    Blood Pressure (BP) will be measured three times using an automated blood pressure cuff with the participant in a seated position. Mean Arterial Pressure will be calculated by the standard formula: Diastolic BP + 1/3 (Systolic BP - Diastolic BP)\] .

    Time frame: Up to 24 months post randomization

  3. Intermediate Behavior: Dietary Adherence

    Repeated 24-hour dietary recalls using the Nutrition Data System for Research (NDSR)

    Time frame: Up to 18 months

  4. Intermediate Behavior: Physical Activity

    Accelerometer, worn for one week.

    Time frame: Up to 18 months

  5. Intermediate Behavior: Medication Adherence

    Morisky 8-item questionnaire (MMAS-8)

    Time frame: Up to 18 months

Other outcomes

  1. Intervention Costs

    Participant and system costs will be collected including, but not limited to: all intervention costs, participant time and travel, clinic visits, emergency department encounters, hospitalizations, and medication costs.

    Time frame: Up to 24 months

07

Study locations

3 sites
  • Rush University Internists
    Chicago, Illinois 60612, United States
  • Erie Family Health Center
    Chicago, Illinois 60622, United States
  • Cicero Health Center of Cook County
    Cicero, Illinois 60804, United States
08

References and documents

Individual participant data

Plan to share: Yes — Deidentified data from the trial will be made available to qualified investigators following completion of the trial and all major data analyses.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 18, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02759484
Responsible party
Sponsor
First posted
May 3, 2016
Start date
Mar 2015
Primary completion
Dec 2018
Completion
Feb 2019
Last update
Aug 18, 2022

Study contacts

Steven K Rothschild, MD
principal investigator · Rush University Medical Center

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion